(Reuters) -Anne Wojcicki is set to regain control of 23andMe after a nonprofit she controls topped Regeneron Pharmaceuticals’ bid for the DNA-testing company for $305 million as part of a bankruptcy auction. Last month, Regeneron agreed to buy the firm for $256 million, topping a $146 million bid from Wojcicki and TTAM Research Institute. “The…
(Reuters) -New York and more than two dozen other U.S. states sued 23andMe to challenge the sale of its customers’ private information after the genetic testing company filed for bankruptcy in March. Twenty seven states, including Pennsylvania, Michigan and Florida, and the District of Columbia filed the lawsuit on Monday in 23andMe’s U.S. bankruptcy proceedings…
WASHINGTON (Reuters) -China is three to six months behind the United States in artificial intelligence, White house AI and crypto czar David Sacks said Tuesday at an event in Washington, warning that excess U.S. AI regulation could damage American innovation in the industry. “China is not years and years behind us in AI. Maybe they’re…
By Abigail Summerville NEW YORK (Reuters) -Pharmacy chain Walgreens and reality star turned entrepreneur Kourtney Kardashian are among those picking over the remaining assets in Rite Aid’s bankruptcy, according to two people familiar with the matter. In addition to Walgreens, brand management companies Authentic Brands Group, WHP Global and Marquee Brands have been evaluating Rite…
By Amanda Stephenson CALGARY (Reuters) -The U.S. relies on Canadian oil imports, despite comments to the contrary by U.S. President Donald Trump, Cenovus Energy CEO said on Tuesday. Trump has threatened on-again, off-again tariffs on Canada’s oil, of which nearly 4 million barrels per day are exported to the United States. Canada is the world’s…
WASHINGTON (Reuters) -U.S. President Donald Trump said on Monday he would support the arrest of California Governor Gavin Newsom over possible obstruction of his administration’s immigration enforcement measures, amid protests in the state. Trump border czar Tom Homan threatened on Saturday to arrest anyone who obstructed enforcement efforts in the state, including Newsom and Los…
(Reuters) -Merck’s oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the development of growth drivers beyond its cancer drugs and vaccines. The company is searching for its next blockbuster candidate as its major revenue driver, Keytruda, is expected to lose patent protection by the end…
By Ross Kerber and Niket Nishant (Reuters) -A lawyer for BlackRock said on Monday that Republican states’ claim that asset managers violated antitrust law through industry climate groups was not “plausible,” as the firms pressed to have the case dismissed. But a lawyer for the states, which include Texas and 12 others, told the U.S….
By Juveria Tabassum (Reuters) -Dollar General raised its annual targets after beating estimates for quarterly profit and same-store sales and said more consumers across income groups came in to shop at its stores amid tariff-related uncertainty and still-high inflation. The forecast lift took the company’s shares up 14% on Tuesday and came in sharp contrast…
By Arsheeya Bajwa (Reuters) -Palantir Technologies has succeeded where most tech stocks have struggled this year: staying hot in a cooling market. The company’s military-grade AI tools along with its deep defense ties and high-level government connections at a time when the U.S. is boosting spending on defense software have helped investors raise the bets…
